Stay In The Know

Join The Discord & Study Up With The Foundation Video Series https://tradejournal.co/connect

    

Live Stream    

Timestamps in video description

https://youtu.be/RUkv0PxMH80

 

    

 

News    

MorningBrew and other sources

 

 

Notes / Research / Recap / Feedback

Winkler's May Recap & June Forecast | 2021

I need to leave Binance (Binance US Customers)

 

 

 

Watchlist

Wednesday

MITO [NASD]
Stealth BioTherapeutics Corp
Healthcare | Biotechnology | Cayman Islands

60% 82mc 5f

Jun-01-21 04:30PM  

 

ACIU [NASD]
AC Immune SA
Healthcare | Biotechnology | Switzerland

20% 485mc 35f

Jun-02-21 07:00AM  

 

BCTX [NASD]
BriaCell Therapeutics Corp.
Healthcare | Biotechnology | Canada

70% 21mc 4f

Breast Cancer reports

  • 12.0 months average overall survival benefit, including 13.4 months in patients with 2+ HLA matches and 12.5 months in patients with Grade I/II tumors(1)
  • Top Responder: 21.4 months survival plus 100% resolution of ‘eye-bulging’ orbital tumor
  • Compares to 7.2-9.8 months survival in historical comparison treatment trials(2)

 

SLNO [NASD]
Soleno Therapeutics, Inc.
Healthcare | Diagnostics & Research | USA

2% 82mc 62f

Jun-02-21 08:00AM  

 

 

 

 

 

Tuesday

VTNR [NASD]
Vertex Energy, Inc.
Energy | Oil & Gas Refining & Marketing | USA

100% 90mc 36f

  • 07:38 AM EDT, 06/01/2021 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)
  • Vertex Energy Inc. shares were recently up 55% at $6.19 after more than doubling on Thursday following Wednesday's announcement of a $75 million deal to buy an Alabama refinery from Royal Dutch Shell PLC.
  • Vertex said the Mobile refinery purchase will be its "largest, most significant transaction ever," positioning it to be "a leading regional supplier of both renewable and conventional products."
  • Shares closed at $1.78 Wednesday.
May-27-21 05:10AM  
May-26-21 04:30PM  

 

 

RTK [NASD]
Paratek Pharmaceuticals, Inc.
Healthcare | Biotechnology | USA

2% 400mc 43f

- Oral-only dosing for the Treatment of CABP Expands the Commercial Opportunity for Primary Care Promotion

- Primary Care Market Opportunity for CABP Estimated at Approximately $1.5 Billion

BOSTON, June 01, 2021 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases and for other public health threats for civilian, government and military use, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s supplemental New Drug Application (sNDA) for the oral-only dosing regimen of NUZYRA® for the treatment of adults with CABP.

 

 

OEG [NASD]
Orbital Energy Group, Inc.
Utilities | Utilities - Diversified | USA

15% 177mc 38f

Jun-01-21 08:05AM  

 

 

 


 

Merch

420 Art is live for Team Winkler on Jeff's website (10% discount code: “AWinkler)

https://www.jeffthe420chef.com/shop?Product+Type=420+Art

Tulip mania art work - (10% Off Code: AlexWinkler)

https://www.annettewinkler.com

TradeJournal Store

https://store.tradejournal.co

 

Sponsors

Free Gap Scanner + Win 2 Free Stocks πŸŽ‰ (Each Up To $1600) πŸ‘‰πŸ‘‰ http://enzlo.com/webull

Best Savings Account Ever! 😍 Win $10 Million - Use Code: WINKLER πŸ‘‰πŸ‘‰ http://enzlo.com/save

Watchlist πŸ‘‰πŸ‘‰ https://tradejournal.co/post/wednesday-pre-market-top-gainers-523/